Medical devices, healthcare technology and the business of care
510(k) clearance · K261057

ActivaScrew Cannulated COM

Bioretec, Ltd. · Decision date Sep 4, 2026

MEDTECHLEDGER EXPLANATIONK261057

What did the FDA decide?

The FDA recorded a substantially equivalent (SESE) decision on September 4, 2026 for ActivaScrew™ Cannulated COM, submitted by Bioretec, Ltd. of Tampere, Finland, under 510(k) number K261057. The device falls under regulation 888.3040, classification name Screw, Fixation, Bone, product code HWC, with an orthopedic review panel. The application was received March 31, 2026, is a traditional 510(k), and was not reviewed by a third party. SESE denotes clearance to market, not premarket approval.

The available FDA letter excerpt references an indication for fixation of bone and osteochondral fractures and osteotomies, dated August 5, 2026, but the excerpt is truncated and the full indication statement is not captured here. The record does not identify a predicate device, summarize the supporting data, or describe any device-specific design changes. Whether the cleared scope matches the indication text as excerpted cannot be confirmed from these sources, so the exact labeled indication should be read from the complete decision letter.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Orthopedic
Decision date
Sep 4, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261057
Regulatory pathway
510(k) premarket notification
Product code
HWC
Decision code
SESE
Decision date
Sep 4, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Screw, Fixation, Bone.

Product code
HWC
FDA device class
2

FDA decision timeline

  1. K261057 received

    Application receipt date recorded by FDA.

  2. K261057 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code HWC

Product / regulatory recordCompanyPathwayDecision dateSource
GM Dos Reis Industria e Comercio Ltda.510(k) clearanceNov 2, 2026FDA
Nvision Biomedical Technologies510(k) clearanceOct 14, 2026FDA
OsteoCentric Technologies510(k) clearanceOct 2, 2026FDA
ARTHREX, INC.510(k) clearanceSep 25, 2026FDA
MEDSHAPE, INC.510(k) clearanceSep 23, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Bioretec, Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Tampere

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records